The anesthetic management for a patient with trisomy 13

Masanori Tsukamoto, Takashi Hitosugi, Kanako Esaki, Takeshi Yokoyama

Research output: Contribution to journalArticlepeer-review

4 Citations (Scopus)


Trisomy 13 is a chromosomal disorder that occurs in complete or partial mosaic forms. It is characterized by central apnea, mental retardation, seizure and congenital heart disease. The survival of the patients with trisomy 13 is the majority dying before one month. Trisomy 13 is the worst life prognosis among all trisomy syndromes. It is reported the cause of death is central apnea. Special needs patients with mental retardation are recognized to have poorer oral health condition. Oral health related quality of life reflects daily activity and well-being. Dental treatment under general anesthesia is sometimes an option for such patients. This patient had received ventricular septal defect closure surgery at 2-year-old. In addition, he had mental retardation and seizure. Dental treatment had been completed without any cerebral and cardiovascular events under non-invasive monitoring with not only cardiac electric velocimetry, but also epileptogenic activity. In addition, postoperative respiratory condition was maintained stable in room air.

Original languageEnglish
Pages (from-to)162-164
Number of pages3
JournalAnesthesia progress
Issue number3
Publication statusPublished - Sept 1 2017

All Science Journal Classification (ASJC) codes

  • Anesthesiology and Pain Medicine


Dive into the research topics of 'The anesthetic management for a patient with trisomy 13'. Together they form a unique fingerprint.

Cite this